Search results
13 wrz 2022 · Starting twice daily flushing of the mucus-lined nasal cavity with a mild saline solution soon after testing positive for COVID-19 can significantly reduce hospitalization and death,...
This randomized clinical trial investigates the efficacy of nasopharyngeal povidone iodine solutions in reducing the viral load of patients with COVID-19.
1 mar 2024 · To assess the efficacy of 0.23% povidone-iodine (PVP-I) nasal rinses and mouth washes on detectability of the coronavirus disease 2019 (COVID-19) virus and cycle threshold (Ct) values in nasopharyngeal swabs. This was an open-label, prospective, randomized, placebo-controlled clinical trial.
27 lut 2023 · The present article focuses on various aspects of nasal spray for eliminating COVID-19. Keywords: SARS-CoV-2, Immunity, Nasal route, Nasal vaccine, Nasal spray, Clinical trials, Devices. Introduction.
Given available evidence, saline irrigations with or without indicated additives may be safe to use in the presence of COVID-19. This is critical to communicate for patients who already use these therapies for rhinosinusitis management.
27 mar 2021 · Clinically, nasal or respiratory airway care with saline reduces symptoms of seasonal coronaviruses and other common cold viruses. Its use as aerosol reduces hospitalization rates for bronchiolitis in children. Preliminary data suggest symptom reduction in symptomatic COVID-19 patients if saline is initiated within 48 h of symptom onset.
28 mar 2020 · Importance Recent studies suggest that theophylline added to saline nasal irrigation (SNI) can be an effective treatment for postviral olfactory dysfunction (OD), a growing public health concern during the COVID-19 pandemic.
